JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mohammed, S.
Right arrow Articles by Yard, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mohammed, S.
Right arrow Articles by Yard, A. C.
Journal of Pharmacology And Experimental Therapeutics, Vol. 156, Issue 2, 221-226, 1967
Copyright © 1967 by American Society for Pharmacology and Experimental Therapeutics


MECHANISM OF THE VASODILATOR RESPONSE TO PHENIPRAZINE

Shakil Mohammed 1, Harold F. Hardman 1, and Albert C. Yard 1

1 Department of Pharmacology, Marquette University, School of Medicine, Milwaukee, Wisconsin

Pheniprazine (beta-phenylisopropylhydrazine, JB 516), an inhibitor of monoamine oxidase, when given i.v. to anesthetized dogs, produced a biphasic arterial blood pressure response, consisting of an immediate transient depressor response followed by a sustained pressor effect. The mechanism of the depressor response to pheniprazine was investigated utilizing intact dogs and also the perfused foreleg in dogs in which the pressor response was blocked. Vasodilatation to i.v. pheniprazine occurred in the perfused foreleg and was not diminished by acute denervation, thus eliminating a neurogenic mechanism. Other possibilities were studied in the denervated foreleg by comparing responses to histamine, acetylcholine or isoproterenol with those to pheniprazine before and after specific antagonists, viz., diphenhydramine, atropine and pronethalol, respectively. Only pronethalol reduced the response to pheniprazine; however, the degree of blockade of pheniprazine was much less than that of isoproterenol. Depletion of catecholamines and serotonin by reserpine pretreatment did not alter the depressor response to pheniprazine. It is concluded that the hypotensive response to pheniprazine does not resemble that caused by histamine or acetylcholine and is not altered by reserpine pretreatment. It appears to be partly due to the stimulation of beta-adrenergic receptors.

Submitted on November 24, 1965
Accepted on November 16, 1966







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics.